RDRasmus Kaae Dehli

Rasmus Kaae Dehli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rasmus Kaae Dehli has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Author Correction: Early-life colonization by aromatic-lactate-producing bifidobacteria lowers the risk of allergic sensitization

    by Pernille Neve Myers, Rasmus Kaae Dehli, Axel Mie, Janne Marie Moll, Henrik Munch Roager, Carsten Eriksen, Martin Frederik Laursen, Ellen Magdalena Staudinger, Ioanna Chatzigiannidou, Pi Lærke Johansen, et al.

  • Open Access

    Gut microbiota composition outperforms chronological age in predicting systemic inflammation and incident disease risk

    by Carsten Eriksen, Ioanna Chatzigiannidou, Rasmus Kaae Dehli, Pi Lærke Johansen, Thomas Meinertz Dantoft, Oluf Pedersen, Torben Hansen, Allan Linneberg, Tine Jess, Kristine Højgaard Allin, et al.

    Low-grade systemic inflammation increases with age and accompanies many age-associated lifestyle-related diseases, yet substantial inter-individual variability exists beyond chronological age. Given the gut microbiota’s role in immune regulation, we analyzed paired fecal microbiota profiles, 30 plasma cytokines, and 19 biochemical and physiological measures in 1,199 adults (aged 20-72) from the population-based DanFunD cohort to assess the relative associations of microbiota composition and age with systemic inflammation and subsequent disease risk. Here we show that despite an association between age and 40% of inflammatory cytokines and most physiological variables, gut microbiota composition explained more variance than age for 97% of cytokines and 84% of physiological variables. Individuals with the Bacteroides 2 enterotype exhibited elevated pro-inflammatory cytokines and adverse metabolic profiles already in early adulthood, displaying an inflammaging-like phenotype up to 37 years earlier than other enterotypes. This enterotype was associated with increased risk of future incident disease across multiple organ systems (hazard ratio 1.21), with mediation analyses suggesting that inflammatory cytokines accounted for part of this association. Conversely, a high-diversity enterotype was linked to lower inflammation and reduced disease risk. These findings position gut microbiota composition as a stronger correlate of systemic inflammatory tone than chronological age and a potentially modifiable determinant of inflammation-related disease trajectories across adulthood.


  • Top Cited Papers

    Early-life colonization by aromatic-lactate-producing bifidobacteria lowers the risk of allergic sensitization

    by Pernille Neve Myers, Rasmus Kaae Dehli, Axel Mie, Janne Marie Moll, Henrik Munch Roager, Carsten Eriksen, Martin Frederik Laursen, Ellen Magdalena Staudinger, Ioanna Chatzigiannidou, Pi Lærke Johansen, et al.

    Early-life microbial exposures shape immune development and allergy risk. Food allergen sensitization, reflected by the presence of food allergen-specific immunoglobulin E (IgE), is an early indication of impaired immune tolerance. Here we show that early-life transmission of aromatic lactate-producing bifidobacteria strains in 147 children followed from birth to 5 years of age, facilitated by vaginal delivery, exposure to older siblings and exclusive breastfeeding for the first 2 months, led to increased levels of aromatic lactates in the infant gut. This microbiota–metabolite signature was inversely associated with the development of food allergen-specific IgE until 5 years and atopic dermatitis at 2 years. The observed effect was mediated by 4-hydroxy-phenyllactate, which inhibited IgE, but not IgG, production in ex vivo human immune cell cultures. Together, these findings define an early-life microbiota–metabolite–immune axis linking microbial transmission and feeding practices with reduced allergic sensitization.


  • Open Access

    Temporal dynamics and microbial interactions shaping the gut resistome in early infancy

    by Ioanna Chatzigiannidou, Pi L. Johansen, Rasmus K. Dehli, Janne Marie Moll, Carsten Eriksen, Pernille N. Myers, Henrik M. Roager, Lili Yang, Jakob Stokholm, Søren J. Sørensen, et al.

    Despite the critical role of the gut resistome in spreading of antimicrobial resistance (AMR), strategies to reduce the abundance of antibiotic resistance genes (ARGs) during microbiota development in infancy remain underexplored. Using longitudinal quantitative metagenomic data, we here show that ARGs are present in the gut microbiota from the first week of life, with a peak in absolute ARG abundance and richness at 6 months. Delivery mode significantly affects early ARG dynamics, and vaginally delivered infants exhibit higher ARG abundance due to maternal transmission of Escherichia coli strains harbouring extensive resistance repertoires. The abundance of E. coli and other ARG-rich taxa inversely correlates with aromatic lactic acid-producing bifidobacteria, and aromatic lactic acids strongly inhibit the in vitro growth of E. coli and other opportunistic ARG-rich taxa. Our results highlight temporal and critical microbial interactions shaping the gut resistome in early infancy, pointing to potential interventions to curb AMR during this vulnerable developmental window by promoting colonization of aromatic lactic acid-producing bifidobacteria.


  • Open Access

    IgG and IgM cooperate in coating of intestinal bacteria in IgA deficiency

    by Carsten Eriksen, Janne Marie Moll, Pernille Neve Myers, Ana Rosa Almeida Pinto, Niels Banhos Danneskiold-Samsøe, Rasmus Ibsen Dehli, Lisbeth Buus Rosholm, Marlene Danner Dalgaard, John Penders, Daisy Mae Jonkers, et al.

    Immunoglobulin A (IgA) is acknowledged to play a role in the defence of the mucosal barrier by coating microorganisms. Surprisingly, IgA-deficient humans exhibit few infection-related complications, raising the question if the more specific IgG may help IgM in compensating for the lack of IgA. Here we employ a cohort of IgA-deficient humans, each paired with IgA-sufficient household members, to investigate multi-Ig bacterial coating. In IgA-deficient humans, IgM alone, and together with IgG, recapitulate coating of most bacterial families, despite an overall 3.6-fold lower Ig-coating. Bacterial IgG coating is dominated by IgG1 and IgG4. Single-IgG2 bacterial coating is sparse and linked to enhanced Escherichia coli load and TNF-α. Although single-IgG2 coating is 1.6-fold more prevalent in IgA deficiency than in healthy controls, it is 2-fold less prevalent than in inflammatory bowel disease. Altogether we demonstrate that IgG assists IgM in coating of most bacterial families in the absence of IgA and identify single-IgG2 bacterial coating as an inflammatory marker.